Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-
|
|
Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Eigenschaften
- Siedepunkt:
- 736.6±70.0 °C(Predicted)
- Dichte
- 1.40±0.1 g/cm3(Predicted)
- pka
- 5.51±0.20(Predicted)
Sicherheit
Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Chemische Eigenschaften,Einsatz,Produktion Methoden
Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 2)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Aktinos Pharma Pvt Ltd | -- |
aktinospharma@aktinos.in | India | 42 | 58 |
Apicore Pharmaceuticals Pvt Ltd | -- |
support@apicore.com | India | 181 | 58 |
- Imidazo[4,5-d][1,3]diazepin-8(3H)-one, 3-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-4,7-dihydro-
- 3-[2-Deoxy-3,5-di-O-para-toluoyl-beta-D-erythro-pentofuranosyl]-6,7-Dihydroimidazo[4,5-d][1,3]diazepin-8(3H)-one
- 72079-79-9